France· FR:66525842
QUTENZA 179 mg, patch cutané
A medicinal product containing capsaïcine, registered in France by GRUNENTHAL.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CAPSAÏCINE
- Manufacturer
- GRUNENTHAL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009576838491 sachet constitué d’aluminium et de téréphtalate de polyéthylène de 1 patch + 1 gel nettoyant de 50 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Capsaïcine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandQutenzaOrifarm Oy
- SpainQUTENZA 179 mg PARCHE CUTANEOGrünenthal Gmbh
- United KingdomQutenza 179mg cutaneous patchesGrunenthal Ltd
- IrelandQutenza 179 mg cutaneous patchGrünenthal GmbH
- IcelandQutenzaGrünenthal GmbH*
- NetherlandsQutenza 179 mg, HuidpleisterGrunenthal GmbH
- NorwayQutenzaGrünenthal GmbH (1)
- BelgiumQutenza 179 mgGrünenthal
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Abc Lokale Schmerz-Therapie Wärme
- Germany · Abc Lokale Schmerz-Therapie Wärme
- Spain · Alacapsin, Capsicin
- United Kingdom (Northern Ireland) · Axsain, Capsaicin Ennogen Ip
- Greece · Capsaxin, Capser
- Ireland · Axsain, Zacin
- Iceland · Capsina, Qutenza
- Liechtenstein · Qutenza
- Norway · Capsina, Qutenza
- Portugal · Neodor
- Sweden · Capsina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6d428461-cb70-46f3-95fd-90563714a850 GET /v1/drugs/6d428461-cb70-46f3-95fd-90563714a850?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66525842",
"date_amm": "2009-05-15",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/09/524",
"substance": "CAPSAÏCINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "patch et gel",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about capsaïcine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.